The Bancorp (NASDAQ:TBBK) reported quarterly earnings of $0.50 per share which beat the analyst consensus estimate of $0.42 by 19.05 percent. This is a 42.86 percent increase over earnings of $0.35 per share from the same period last year.
Stifel Downgrades Applied Genetic Techs to Hold, Lowers Price Target to $0.34
Stifel analyst Dae Gon Ha downgrades Applied Genetic Techs (NASDAQ:AGTC) from Buy to Hold and lowers the price target from $3 to $0.34.